MedTrace Logo

Transatlantic Active Surveillance on Cardiovascular Safety of NuvaRing (TASC)

NCT00524771 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 34100

Last updated 2014-04-09

Study results available
· View outcomes & findings →

Summary

The objective of this study is to characterize and compare the risks of short- and long-term use of NuvaRing® with marketed combined oral contraceptives.

Conditions

  • Contraception

Sponsors & Collaborators

  • Organon

    collaborator INDUSTRY

  • Center for Epidemiology and Health Research, Germany

    lead OTHER

Principal Investigators

  • Juergen C Dinger, MD, PhD · Center for Epidemiology and Health Research Berlin, Germany

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-09-30
Primary Completion
2012-03-31
Completion
2012-06-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00524771 on ClinicalTrials.gov